» Articles » PMID: 7507859

Sl/Sld Hematopoietic Progenitors Are Deficient in Situ

Overview
Journal Exp Hematol
Specialty Hematology
Date 1994 Feb 1
PMID 7507859
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The hematopoietic microenvironment in Steel mutant mice does not support erythropoiesis, megakaryocytopoiesis, or mast cell generation. The question of whether Steel hematopoietic progenitors are present in normal numbers has never been convincingly addressed. In this report, Sl/Sld marrow cells were assessed for long-term competitive repopulation ability in vivo and for short-term growth in vitro. In vivo repopulation assays indicate that the Sl/Sld progenitors are at a distinct disadvantage when they compete against congenic genetically marked +/+ cells in a +/+ host. On the other hand, the Steel erythroid colony-forming cells (CFU-E) respond normally to erythropoietin (Epo) in vitro and are present at normal frequency. Because the Steel marrow is less cellular than normal marrow, the absolute number of CFU-E is decreased. Results suggest that the absence of membrane-bound Steel factor in the mutant donor has a direct effect on Steel hematopoietic progenitors, which is not alleviated during growth for over 6 months in a normal microenvironment. The anomaly does not seem to directly affect the frequency of more mature adult erythroid progenitors.

Citing Articles

Influences on the Hematopoietic Stem Cell Niche.

Wang W, Brown T, Barth B SciBase Hematol Blood Disord. 2024; 1(1).

PMID: 39429505 PMC: 11486556.


Variation in mesenchymal KITL/SCF and IGF1 expression in middle age underlies steady-state hematopoietic stem cell aging.

Young K, Telpoukhovskaia M, Hofmann J, Mistry J, Kokkaliaris K, Trowbridge J Blood. 2024; 144(4):378-391.

PMID: 38598841 PMC: 11302459. DOI: 10.1182/blood.2024024275.


Loss of endothelial membrane KIT ligand affects systemic KIT ligand levels but not bone marrow hematopoietic stem cells.

Matsuoka S, Facchini R, Luis T, Carrelha J, Woll P, Mizukami T Blood. 2023; 142(19):1622-1632.

PMID: 37562000 PMC: 10733828. DOI: 10.1182/blood.2022019018.


Tumor-derived interleukin-1α and leukemia inhibitory factor promote extramedullary hematopoiesis.

Barisas D, Kabir A, Wu J, Krchma K, Kim M, Subramanian M PLoS Biol. 2023; 21(5):e3001746.

PMID: 37134077 PMC: 10155962. DOI: 10.1371/journal.pbio.3001746.


Metabolic crosstalk between stromal and malignant cells in the bone marrow niche.

Tirado H, Balasundaram N, Laaouimir L, Erdem A, van Gastel N Bone Rep. 2023; 18:101669.

PMID: 36909665 PMC: 9996235. DOI: 10.1016/j.bonr.2023.101669.